Soluble low-density lipoprotein receptor-related protein 1 as a surrogate marker of carotid plaque inflammation assessed by ¹⁸ F-FDG PET in patients with a recent ischemic stroke.

Autor: Garcia E; Lipids and Cardiovascular Pathology, Institut d'Investigacions Biomèdiques de Barcelona (IIBB)-Spanish National Research Council (CSIC), Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Quintí 77-79, 08041, Barcelona, Spain.; Universitat Autònoma de Barcelona, Barcelona, Spain., Camps-Renom P; Stroke Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, IIB SANT PAU, Barcelona, Spain., Puig N; Cardiovascular Biochemistry, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Quintí 77-79, 08041, Barcelona, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), Building M, Cerdanyola del Vallés, Barcelona, Spain., Fernández-Leon A; Department of Nuclear Medicine, Hospital de la Santa Creu i Sant Pau, IIB SANT PAU, Barcelona, Spain., Aguilera-Simón A; Stroke Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, IIB SANT PAU, Barcelona, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), Building M, Cerdanyola del Vallés, Barcelona, Spain., Benitez-Amaro A; Lipids and Cardiovascular Pathology, Institut d'Investigacions Biomèdiques de Barcelona (IIBB)-Spanish National Research Council (CSIC), Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Quintí 77-79, 08041, Barcelona, Spain., Solé A; Stroke Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, IIB SANT PAU, Barcelona, Spain., Vilades D; Cardiac Imaging Unit, Department of Cardiology, Hospital de la Santa Creu i Sant Pau, IIB SANT PAU, Barcelona, Spain.; CIBER of Cardiovascular (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain., Sanchez-Quesada JL; Cardiovascular Biochemistry, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Quintí 77-79, 08041, Barcelona, Spain.; CIBER of Diabetes and Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain., Martí-Fàbregas J; Stroke Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, IIB SANT PAU, Barcelona, Spain., Jiménez-Xarrié E; Stroke Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, IIB SANT PAU, Barcelona, Spain., Benitez S; Cardiovascular Biochemistry, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Quintí 77-79, 08041, Barcelona, Spain. sbenitez@santpau.cat.; CIBER of Diabetes and Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain. sbenitez@santpau.cat., Llorente-Cortés V; Lipids and Cardiovascular Pathology, Institut d'Investigacions Biomèdiques de Barcelona (IIBB)-Spanish National Research Council (CSIC), Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Sant Quintí 77-79, 08041, Barcelona, Spain. vicenta.llorente@iibb.csic.es.; CIBER of Cardiovascular (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain. vicenta.llorente@iibb.csic.es.

Publikováno v: Journal of translational medicine [J Transl Med] 2023 Feb 19; Vol. 21 (1), pp. 131. Date of Electronic Publication: 2023 Feb 19.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Increased sLRP1 and decreased atrial natriuretic peptide plasma levels in newly diagnosed T2DM patients are normalized after optimization of glycemic control.

Autor: García E; Institut de Recerca de l'Hospital de la santa Creu i Sant Pau, Sant Quintí, Barcelona, Spain.; Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Quintí, Barcelona, Spain.; Institute of Biomedical Research of Barcelona (IIBB), Spanish National Research Council (CSIC), Barcelona, Spain.; Universitat Autònoma de Barcelona, Barcelona, Spain., Gil P; Endocrinology and Nutrition Service, Hospital de la Santa Creu i Sant Pau, Sant Quintí, Barcelona, Spain., Miñambres I; Endocrinology and Nutrition Service, Hospital de la Santa Creu i Sant Pau, Sant Quintí, Barcelona, Spain., Benitez-Amaro A; Institut de Recerca de l'Hospital de la santa Creu i Sant Pau, Sant Quintí, Barcelona, Spain.; Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Quintí, Barcelona, Spain.; Institute of Biomedical Research of Barcelona (IIBB), Spanish National Research Council (CSIC), Barcelona, Spain., Rodríguez C; Endocrinology and Nutrition Service, Hospital de la Santa Creu i Sant Pau, Sant Quintí, Barcelona, Spain., Claudi L; Institut de Recerca de l'Hospital de la santa Creu i Sant Pau, Sant Quintí, Barcelona, Spain.; Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Quintí, Barcelona, Spain.; Institute of Biomedical Research of Barcelona (IIBB), Spanish National Research Council (CSIC), Barcelona, Spain., Julve J; Institut de Recerca de l'Hospital de la santa Creu i Sant Pau, Sant Quintí, Barcelona, Spain.; Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Quintí, Barcelona, Spain.; Endocrinology and Nutrition Service, Hospital de la Santa Creu i Sant Pau, Sant Quintí, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain., Benitez S; Institut de Recerca de l'Hospital de la santa Creu i Sant Pau, Sant Quintí, Barcelona, Spain.; Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Quintí, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain., Sánchez-Quesada JL; Institut de Recerca de l'Hospital de la santa Creu i Sant Pau, Sant Quintí, Barcelona, Spain.; Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Quintí, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain., Rives J; Institut de Recerca de l'Hospital de la santa Creu i Sant Pau, Sant Quintí, Barcelona, Spain.; Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Quintí, Barcelona, Spain., Garcia-Moll X; Cardiology Department, Santa Creu i Sant Pau University Hospital, Barcelona, Spain., Vilades D; Cardiology Department, Santa Creu i Sant Pau University Hospital, Barcelona, Spain.; Cardiac Imaging Unit, Cardiology Department, Santa Creu i Sant Pau University Hospital, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Institute of Health Carlos III, Madrid, Spain., Perez A; Endocrinology and Nutrition Service, Hospital de la Santa Creu i Sant Pau, Sant Quintí, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain., Llorente-Cortes V; Institut de Recerca de l'Hospital de la santa Creu i Sant Pau, Sant Quintí, Barcelona, Spain.; Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Quintí, Barcelona, Spain.; Institute of Biomedical Research of Barcelona (IIBB), Spanish National Research Council (CSIC), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Institute of Health Carlos III, Madrid, Spain.

Publikováno v: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Aug 10; Vol. 14, pp. 1236487. Date of Electronic Publication: 2023 Aug 10 (Print Publication: 2023).

Plasma circular RNA hsa_circ_0001445 and coronary artery disease: Performance as a biomarker.

Autor: Vilades D; Cardiac Imaging Unit, Cardiology Service, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Martínez-Camblor P; Geisel School of Medicine, Dartmouth College, Hanover, NH, USA., Ferrero-Gregori A; Cardiology Service, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; CIBER Cardiovascular (CIBERCV), Institute of Health Carlos III, Madrid, Spain., Bär C; Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany.; REBIRTH Center for Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany., Lu D; Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany., Xiao K; Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany., Vea À; Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain., Nasarre L; Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain., Sanchez Vega J; Cardiac Imaging Unit, Cardiology Service, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Leta R; Cardiac Imaging Unit, Cardiology Service, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain., Carreras F; Cardiac Imaging Unit, Cardiology Service, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; CIBER Cardiovascular (CIBERCV), Institute of Health Carlos III, Madrid, Spain.; Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain., Thum T; Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany.; REBIRTH Center for Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany., Llorente-Cortés V; CIBER Cardiovascular (CIBERCV), Institute of Health Carlos III, Madrid, Spain.; Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.; Institute of Biomedical Research of Barcelona (IIBB), Spanish National Research Council (CSIC), Barcelona, Spain., de Gonzalo-Calvo D; CIBER Cardiovascular (CIBERCV), Institute of Health Carlos III, Madrid, Spain.; Institute of Molecular and Translational Therapeutic Strategies (IMTTS), Hannover Medical School, Hannover, Germany.; Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.; Institute of Biomedical Research of Barcelona (IIBB), Spanish National Research Council (CSIC), Barcelona, Spain.

Publikováno v: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2020 Mar; Vol. 34 (3), pp. 4403-4414. Date of Electronic Publication: 2020 Jan 30.

Short-term hemodynamic effects of beta-blockers influence survival of patients with decompensated cirrhosis

Autor: Alvarado-Tapias, E, Ardevol, A, Garcia-Guix, M, Montanes, R, Pavel, O, Cuyas, B, Graupera, I, Brujats, A, Vilades, D, Colomo, A, Poca, M, Torras, X, Guarner, C, Concepcion, M, Aracil, C, Torres, F, Villanueva, C

Publikováno v: JOURNAL OF HEPATOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)

Background & Aims: Whether the effect of beta-blockers on arterial pressure and/or cardiac function may offset the benefit of reducing portal pressure in advanced cirrhosis is controversial. Herein, we aimed to evaluate the systemic and splanchnic he

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6401464a11da164bdd443b6ac137125f
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1412